Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 10 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

10%

1 trials in Phase 3/4

Results Transparency

0 of 4 completed trials have results

Key Signals

3 recruiting

Enrollment Performance

Analytics

N/A

5(62.5%)

Phase 1

1(12.5%)

Phase 4

1(12.5%)

Phase 2

1(12.5%)

8Total

N/A(5)

Phase 1(1)

Phase 4(1)

Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (10)

Showing 10 of 10 trials

NCT04276220Not ApplicableCompleted

Prevalence of wtATTR-CM After Carpal Tunnel Release Surgery

Role: lead

NCT06291805Recruiting

Phenotyping and Characterization of wtATTR-CM (TRACE 1)

Role: lead

NCT05633563Phase 4Completed

The Effect of Trimetazidine on Mitochondrial Function, Myocardial Performance, and Invasive Hemodynamics in Patients Diagnosed With Wild-Type Transthyretin Cardiac Amyloidosis

Role: lead

NCT06372301Not ApplicableRecruiting

Dobutamine Stress Echocardiography in LF/LG Aortic Stenosis and Wild-type Transthyretin Amyloid Cardiomyopathy

Role: lead

NCT06318260Phase 1Recruiting

Haemodynamic Effects of Dobutamine in Patients With Wild-type Transthyretin Amyloid Cardiomyopathy (ATTRwt)

Role: lead

NCT04066777Not ApplicableCompleted

The Effect of TASH in Patients With HOCM

Role: lead

NCT05699044Unknown

Screening of ATTRwt in Patient With Advanced AV-Block Undergoing Pacemaker Implantation

Role: lead

NCT05701410Not ApplicableUnknown

Prevalence of Cardiac Amyloidosis Among Patients With a History of Lumbar Spinal Stenosis.

Role: lead

NCT05701397Not ApplicableUnknown

Prevalence of Cardiac Amyloidosis in Patients Undergoing Surgery for Lumbar Spinal Stenosis.

Role: lead

NCT03532802Phase 2Completed

The Effect of Metoprolol in Patients With Hypertrophic Obstructive Cardiomyopathy.

Role: lead

All 10 trials loaded